Ginkgo Bioworks Advances Collaboration with Merck to Improve …
2 days ago · DNABW. BOSTON, Nov. 12, 2024 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced the completion of the first ...
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
2 days ago · Ginkgo updates its previously issued guidance solely to reflect the impact of the previously mentioned $45 million non-cash deferred revenue release in the third quarter to: Total revenue guidance ...
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
2 days ago · Ginkgo Bioworks Holdings, Inc. (NYSE: DNA, "Ginkgo"), which is building the leading platform for cell programming and biosecurity, today announced its results for the third quarter ended September ...
Ginkgo Bioworks Reports Third Quarter 2024 Financial Results
3 days ago · Third Quarter 2024 Financial Results. Third quarter 2024 Total revenue of $89 million, up from $55 million in the comparable prior year period, an increase of 61% driven by $45 million of non-cash ...
Advancing our Collaboration with Merck to to Improve Biologics ...
3 days ago · November 12, 2024. Today, we’re pleased to announce the completion of the first milestone of a previously announced partnership with Merck, known as MSD outside of the United States and Canada, focused on improving biologic manufacturing. As part of this milestone completion, Ginkgo will receive a research milestone payment of $9 million in cash.
Ginkgo Bioworks Holdings Inc (DNA) Q3 2024 Earnings Call …
1 day ago · Ginkgo Bioworks Holdings Inc (DNA) Q3 2024 Earnings Call Highlights: Strategic Restructuring ... Biosecurity Revenue: $14 million in Q3 2024. Gross Margin: 28% for the biosecurity business, down ...
Ginkgo Bioworks Advances Collaboration with Merck to Improve …
2 days ago · News provided by Ginkgo Bioworks Nov 12, 2024, 08:01 ET. Share this article. Share to X. Share this article. Share to X. BOSTON, Nov. 12 ...
Engineering Stable mRNA: Insights from ML-Driven Design of 3′ …
Nov 4, 2024 · Today, we’re excited to announce Ginkgo AI’s newest research release. You can read it in full on bioRxiv here.Or check out a video summary of the work here.. In short, we generated a dataset measuring mRNA stability for 180,000 unique sequences, used it to train a machine learning model mapping mRNA stability to the 3’UTR sequence, then used the model to design new RNAs with improved ...
High-Throughput Data at New Scales: How to get our industry …
October 23, 2024. Today, we’re excited to announce the launch of our Antibody Developability product, an offering that pushes the envelope of biological data generation, designed to accelerate biologics development by providing high-quality, AI …
Ginkgo Bioworks Reports 61% Revenue Jump in Q3 2024
2 days ago · The latest update is out from Ginkgo Bioworks Holdings ( (DNA) ).Ginkgo Bioworks reported a significant revenue increase of 61% in Q3 2024, primarily due to a $45 million non-cash deferred revenue ...
- Some results have been removed